Literature DB >> 28139238

New developments in the medical treatment of endometriosis.

Mohamed A Bedaiwy1, Sukinah Alfaraj2, Paul Yong2, Robert Casper3.   

Abstract

Endometriosis affects 1 in 10 women of reproductive-age. The current treatments are surgical and hormonal but have limitations, including the risk of recurrence, side effects, contraceptive action for women who desire pregnancy, and cost. New treatments include gonadotropin-releasing hormone analogues, selective progesterone (or estrogen) receptor modulators, aromatase inhibitors, immunomodulators, and antiangiogenic agents. Further research is needed into central sensitization, local neurogenesis, and the genetics of endometriosis to identify additional treatment targets. A wider range of medical options allows for the possibility of precision health and a more personalized treatment approach for women with endometriosis.
Copyright © 2017 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antiangiogenic agents; endometriosis; future medical therapy; immunomodulators

Mesh:

Substances:

Year:  2017        PMID: 28139238     DOI: 10.1016/j.fertnstert.2016.12.025

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  29 in total

Review 1.  Endometriosis and nuclear receptors.

Authors:  Bahar D Yilmaz; Serdar E Bulun
Journal:  Hum Reprod Update       Date:  2019-07-01       Impact factor: 15.610

2.  Human Endometriosis Tissue Microarray Reveals Site-specific Expression of Estrogen Receptors, Progesterone Receptor, and Ki67.

Authors:  Mariano Colón-Caraballo; Miosotis García; Adalberto Mendoza; Idhaliz Flores
Journal:  Appl Immunohistochem Mol Morphol       Date:  2019-08

Review 3.  Drug delivery for the treatment of endometriosis and uterine fibroids.

Authors:  David R Friend
Journal:  Drug Deliv Transl Res       Date:  2017-12       Impact factor: 4.617

4.  SR-16234, a Novel Selective Estrogen Receptor Modulator for Pain Symptoms with Endometriosis: An Open-label Clinical Trial.

Authors:  Tasuku Harada; Ikuko Ohta; Yusuke Endo; Hiroshi Sunada; Hisashi Noma; Fuminori Taniguchi
Journal:  Yonago Acta Med       Date:  2018-02-05       Impact factor: 1.641

5.  HORMONAL THERAPY IN WOMEN OF REPRODUCTIVE AGE WITH ENDOMETRIOSIS: AN UPDATE.

Authors:  A A Gheorghisan-Galateanu; M L Gheorghiu
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Apr-Jun       Impact factor: 0.877

6.  Elevated levels of adrenomedullin in eutopic endometrium and plasma from women with endometriosis.

Authors:  Brooke C Matson; Kelsey E Quinn; Bruce A Lessey; Steven L Young; Kathleen M Caron
Journal:  Fertil Steril       Date:  2018-06-02       Impact factor: 7.329

Review 7.  MicroRNAs in endometriosis: biological function and emerging biomarker candidates†.

Authors:  Sarah Bjorkman; Hugh S Taylor
Journal:  Biol Reprod       Date:  2019-05-01       Impact factor: 4.285

8.  Estrogen is essential but not sufficient to induce endometriosis.

Authors:  Mosami Galvankar; Neha Singh; Deepak Modi
Journal:  J Biosci       Date:  2017-06       Impact factor: 1.826

9.  Bufalin suppresses endometriosis progression by inducing pyroptosis and apoptosis.

Authors:  Yeon Jean Cho; Jiyeun E Lee; Mi Jin Park; Bert W O'Malley; Sang Jun Han
Journal:  J Endocrinol       Date:  2018-04-10       Impact factor: 4.286

Review 10.  Intricate Connections between the Microbiota and Endometriosis.

Authors:  Irene Jiang; Paul J Yong; Catherine Allaire; Mohamed A Bedaiwy
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.